journal article·2026

Employing pH/reactive oxygen species (ROS) dual-responsive chitosan/oxidized dextran composite hydrogels based on dual-dynamic bonding to enhance regeneration and repair in diabetic wounds

Jige Yuan, Kun Qian, Qu Tang, Jialin Yao, Jiamin Chen, Tiantian Shen, Haiwei Ji, Yuling Qin, Chenxia Jiang, Li Wu

Publisher page

Abstract

Diabetic wounds pose considerable therapeutic challenges owing to impaired tissue regeneration and elevated risk of bacterial infection. This study developed a hydrogel-based microenvironment-responsive multifunctional composite system. This composite material comprises a pH/reactive oxygen species (ROS) dual-responsive hydrogel scaffold formed by dihydrocaffeic acid-grafted chitosan and phenylboronic acid-functionalized oxidized dextran hinges, encapsulating gallium ions and ROS-responsive curcumin micelles. Taking advantage of the acidic microenvironment (pH 4.5-6.5) and elevated ROS levels in diabetic wounds, the composites exhibit significant efficacy in inhibiting bacterial biofilm formation, scavenging excess ROS, alleviating inflammatory responses, significantly promoting angiogenesis and collagen deposition. This integrated strategy successfully addresses major challenges in diabetic wound treatment-namely, susceptibility to infection, persistent inflammation, elevated oxidative stress, and impaired angiogenesis by enabling synergistic regulation of antibacterial, anti-inflammatory, antioxidant, and pro-regenerative effects. This comprehensive strategy bridges antimicrobial defense and immune regulation in the context of comprehensive wound management, thereby providing a valuable reference for the development of effective clinical therapies for diabetic wounds.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Public Health, Nantong Key Laboratory of Public Health and Medical Analysis, Jiangsu Key Laboratory of Advanced Medical Analysis and Public Health, Nantong University, 9 Seyuan Road, Nantong 226019, Jiangsu, China

Department of Laboratory Medicine, Affiliated Hospital of Nantong University, No. 20, Xisi Road, Nantong 226001, Jiangsu, China

The Jiangsu Province Boron Neutron Capture Therapy Center for Multi-Cancer Precision Targeted Treatment Technology and Engineering Research, Affiliated Hospital of Nantong University, No. 20, Xisi Road, Nantong 226001, Jiangsu, China

Funding

National Natural Science Foundation of China · Excellent Youth Foundation of Jiangsu Scientific Committee · Nantong University

References (38)

Show source-provided references
1. Wilson · Lancet · 2018 · 391 · 192710.1016/S0140-6736(18)30458-6 ↗
2. He · Int. Immunopharmacol. · 2024 · 132 · 11199010.1016/j.intimp.2024.111990 ↗
3. Falanga · Lancet · 2005 · 366 · 173610.1016/S0140-6736(05)67700-8 ↗
4. Kim · Adv. Sci. · 2019 · 6 · 190051310.1002/advs.201900513 ↗
5. Matoori · Sci. Transl. Med. · 2021 · 13 · eabe483910.1126/scitranslmed.abe4839 ↗
6. Bakkeren · Nat. Rev. Microbiol. · 2020 · 18 · 47910.1038/s41579-020-0378-z ↗
7. Li · J. Controlled Release · 2026 · 393 · 11481510.1016/j.jconrel.2026.114815 ↗
8. Zhang · Innovation · 2023 · 4 · 10050
9. Zheng · Biomed. Pharmacother. · 2023 · 165 · 11519910.1016/j.biopha.2023.115199 ↗
10. Wang · J. Am. Chem. Soc. · 2025 · 147 · 1636210.1021/jacs.5c02184 ↗
11. Xie · Adv. Healthcare Mater. · 2025 · 14 · 240519010.1002/adhm.202405190 ↗
12. Kharaziha · Adv. Mater. · 2021 · 33 · e210017610.1002/adma.202100176 ↗
13. Liu · Sci. Adv. · 2022 · 8 · eabn700610.1126/sciadv.abn7006 ↗
14. Qu · Biomaterials · 2018 · 183 · 18510.1016/j.biomaterials.2018.08.044 ↗
15. Fan · J. Mater. Chem. B · 2024 · 12 · 552510.1039/D4TB00594E ↗
16. Yang · Adv. Sci. · 2024 · 11 · e240321910.1002/advs.202403219 ↗
17. Hong · ACS Nano · 2025 · 19 · 1018010.1021/acsnano.4c17291 ↗
18. Zhang · Food Hydrocolloids · 2024 · 146 · 10918610.1016/j.foodhyd.2023.109186 ↗
19. Xu · Biomaterials · 2015 · 37 · 39510.1016/j.biomaterials.2014.10.024 ↗
20. Hu · Chem. Eng. J. · 2021 · 411 · 12856410.1016/j.cej.2021.128564 ↗
21. Wu · J. Controlled Release · 2022 · 341 · 14710.1016/j.jconrel.2021.11.027 ↗
22. Liang · J. Colloid Interface Sci. · 2019 · 536 · 22410.1016/j.jcis.2018.10.056 ↗
23. Zhong · Biomacromolecules · 2021 · 22 · 165410.1021/acs.biomac.1c00086 ↗
24. Wei · Adv. Funct. Mater. · 2015 · 25 · 135210.1002/adfm.201401502 ↗
25. Bertsch · Chem. Rev. · 2023 · 123 · 83410.1021/acs.chemrev.2c00179 ↗
26. Li · Composites, Part B · 2023 · 266 · 11098410.1016/j.compositesb.2023.110984 ↗
27. Wei · Nat. Nanotechnol. · 2024 · 19 · 117810.1038/s41565-024-01660-y ↗
28. Condo · Gels · 2024 · 10 · 44210.3390/gels10070442 ↗
29. Liang · ACS Nano · 2022 · 16 · 319410.1021/acsnano.1c11040 ↗
30. Mohandas · Bioact. Mater. · 2018 · 3 · 267
31. Douglass · Prog. Mater. Sci. · 2022 · 130 · 10099710.1016/j.pmatsci.2022.100997 ↗
32. Zhang · Carbohydr. Polym. · 2025 · 354 · 12332210.1016/j.carbpol.2025.123322 ↗
33. Chi · Nature · 2024 · 634 · 116810.1038/s41586-024-08022-7 ↗
34. Hasanzadeh · Pharmacol. Res. · 2020 · 159 · 10492110.1016/j.phrs.2020.104921 ↗
35. Karimian · Cytokine Growth Factor Rev. · 2017 · 33 · 5510.1016/j.cytogfr.2016.10.001 ↗
36. Zhang · Mater. Today Bio · 2023 · 18 · 10050810.1016/j.mtbio.2022.100508 ↗
37. Chen · Signal Transduct Target Ther. · 2023 · 8 · 20710.1038/s41392-023-01452-1 ↗
38. Huang · Burns Trauma · 2025 · 13 · tkae05210.1093/burnst/tkae052 ↗